A compliant DSIP COA (Certificate of Analysis) provides empirical, lot-specific documentation verifying the identity, purity, and microbiological safety of synthesized Delta-Sleep-Inducing Peptide. Validated through independent ISO 17025 testing laboratories using RP-HPLC, ESI-MS, and LAL endotoxin assays, an authentic COA ensures that research-grade DSIP meets strict analytical benchmarks required for reproducible in vitro and preclinical investigation.
A compliant DSIP COA (Certificate of Analysis) provides empirical, lot-specific documentation verifying the identity, purity, and microbiological safety of synthesized Delta-Sleep-Inducing Peptide. Validated through independent ISO 17025 testing laboratories using RP-HPLC, ESI-MS, and LAL endotoxin assays, an authentic COA ensures that research-grade DSIP meets strict analytical benchmarks required for reproducible in vitro and preclinical investigation.
A rigorous DSIP COA serves as the primary scientific validation for laboratories investigating Delta-Sleep-Inducing Peptide. To establish high analytical confidence prior to experimental deployment, investigators must examine three core quantitative metrics on every certificate: chromatographic purity, exact molecular mass verification, and endotoxin burden. Without verifiable third-party documentation, minor impurities or truncated peptide fragments can confound experimental assays focused on neuroendocrine pathways or central sleep architecture.
When evaluating a lot-specific DSIP COA, the primary benchmark is purity determined via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). High-grade analytical batches must demonstrate a single prominent peak accounting for at least 98.0% of the total integrated peak area. Furthermore, Electrospray Ionization Mass Spectrometry (ESI-MS) must yield a observed mass matching the theoretical molecular weight of 1059.04 Da within a narrow error margin. Finally, bacterial endotoxin testing via Chromogenic Limulus Amebocyte Lysate (LAL) assays ensures levels remain strictly below regulatory thresholds (<0.01 EU/mg) to prevent non-specific immune activation in cell cultures or animal models.
Delta-Sleep-Inducing Peptide (DSIP) is an endogenous nonapeptide consisting of the amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (MW: 1059.04 g/mol). Discovered via rabbit cerebral venous blood assays during slow-wave sleep induction studies, DSIP represents a unique regulatory peptide capable of crossing the blood-brain barrier via passive diffusion and carrier-mediated transport mechanisms.
In preclinical settings, researchers evaluate DSIP for its capacity to modulate delta-wave (0.5–4 Hz) electroencephalographic activity, attenuate hypothalamic-pituitary-adrenal (HPA) axis hyperreactivity, and reduce oxidative stress. Detailed exploration of its biochemical pathway is available within our DSIP research guide. Because DSIP interacts with central neuromodulatory systems rather than functioning as a direct sedative or classical agonist, chemical purity is vital; trace organic impurities can alter baseline peptide binding affinities or alter enzymatic degradation profiles.
Interpreting a DSIP COA requires navigating two primary analytical data sets: the HPLC chromatogram and the mass spectrum. In the RP-HPLC section, the analyte is separated across a hydrophobic stationary phase using a gradient of acetonitrile and water supplemented with trifluoroacetic acid (TFA). The primary peak corresponding to full-length DSIP should display sharp peak symmetry without co-eluting shoulder peaks, which typically indicate oxidation products (such as oxidized tryptophan residues) or deleted sequence fragments.
The Mass Spectrometry (MS) readout confirms molecular identity. For DSIP, the spectra usually highlight the monoisotopic mass peak [M+H]+ at approximately m/z 1060.04 or multiply charged ions like [M+2H]2+. Verification of these exact mass signatures rules out misidentified synthesis products or structural isomers. PX1 Research publishes lot-specific analytical reports accessible through our central research portal, giving researchers complete transparency prior to procurement.
When designing protocols to investigate neuroendocrine restoration, stress resilience, or circadian rhythm regulation, researchers often analyze DSIP alongside complementary regulatory nonapeptides and synthetic signaling compounds. Evaluating comparative analytical standards ensures proper experimental controls across multi-peptide assays.
For example, researchers studying pineal gland modulation and telomerase expression often utilize Epitalon 10mg, a synthetic tetrapeptide with distinct analytical requirements due to its shorter chain length. Similarly, investigations focused on central nervous system stress pathways frequently compare DSIP to the anxiolytic heptapeptide Selank 10mg or the neuroprotective agent Semax 10mg. For studies involving the growth hormone axis during slow-wave sleep cycles, DSIP is often evaluated in conjunction with growth hormone secretagogues such as Ipamorelin 5mg. Establishing rigorous COA purity baselines across all compounds is necessary to isolate specific receptor interaction effects from baseline chemical noise. Review our complete catalog of verified compounds in the all peptides library.
Endotoxins (lipopolysaccharides derived from the outer membrane of Gram-negative bacteria) represent a severe hazard in cellular and animal model research. Even minor endotoxin contamination in a synthesized peptide lot can induce inflammatory cytokine cascades (such as TNF-alpha and IL-6), leading to false-positive data in neuroendocrine or sleep-wake cycle studies.
PX1 Research subjects every DSIP production batch to quantitative LAL endotoxin testing. By enforcing stringent thresholds (<0.01 EU/mg), our manufacturing processes ensure that observed biological responses can be attributed strictly to the pure nonapeptide sequence rather than pyrogenic contaminants. Laboratories procuring high volumes for extended study protocols can coordinate batch reservation through our wholesale lab portal.
To preserve the structural integrity verified on the DSIP COA, proper laboratory handling and reconstitution procedures must be maintained. Lyophilized DSIP is sensitive to ambient moisture, heat, and structural shear forces during liquid handling.
Reconstitution should be conducted under sterile conditions using Bacteriostatic Water (0.9% benzyl alcohol) or sterile PBS buffer depending on the downstream assay requirements. The solvent should be directed down the glass vial wall rather than sprayed directly onto the lyophilized cake, followed by gentle swirling rather than vortexing to prevent peptide aggregation. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes and stored at -20°C or -80°C to prevent degradation through repeated freeze-thaw cycles.
PX1 Research operates as a premier American scientific supplier dedicated strictly to supplying laboratory-grade research compounds. Every lot of DSIP offered by PX1 is synthesized in state-of-the-art, GMP-compliant facilities within the United States and undergo rigorous analytical verification at independent ISO 17025-accredited laboratories.
Our dual fulfillment centers located in California and Arizona ensure optimal supply chain logistics, providing same-day dispatch for orders placed Monday through Friday before cut-off times. Researchers benefit from fully documented lot traceability, ensuring that the DSIP COA attached to a specific vial perfectly matches the physical sample delivered to the laboratory bench.
What is a DSIP COA?
A DSIP COA (Certificate of Analysis) is an official analytical document provided by an independent laboratory verifying the chemical identity, purity percentage (via RP-HPLC), molecular mass (via Mass Spectrometry), and endotoxin level of a specific lot of Delta-Sleep-Inducing Peptide.
Why is third-party HPLC testing required for DSIP research compounds?
RP-HPLC testing separates the target nonapeptide from residual solvents, side-reaction impurities, and truncated sequences, ensuring the compound meets the strict >98% purity standard required for unconfounded preclinical data.
How does mass spectrometry verify DSIP identity on the COA?
Electrospray Ionization Mass Spectrometry (ESI-MS) measures the precise mass-to-charge ratio of the synthesized peptide. For DSIP, the observed mass must match the theoretical molecular weight of 1059.04 Da.
What endotoxin limits are acceptable on a DSIP COA for laboratory research?
High-purity research-grade DSIP should exhibit endotoxin levels below 0.01 EU/mg as measured by LAL testing to prevent pyrogenic reactions or baseline cytokine activation in cell and animal assays.
Where can I view the lot-specific DSIP COA for my PX1 Research order?
Lot-specific certificates of analysis are accessible directly on the product page for DSIP 5mg or through our centralized analytical portal using the lot number printed on the vial label.
How should lyophilized DSIP be stored upon delivery to the lab?
Lyophilized DSIP should be stored in a freezer at -20°C or -80°C away from light. Under these conditions, the peptide remains stable for extended periods as documented on the analytical stability sheet.
What diluent is recommended for reconstituting DSIP for in vitro assays?
For standard laboratory assays, sterile Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4) is recommended, depending on the requirements of the specific cell culture or analytical protocol.
Are PX1 Research peptides synthesized in the USA?
Yes. All PX1 Research compounds are manufactured in domestic, GMP-compliant facilities and tested by accredited third-party laboratories within the United States.
Can DSIP stock solutions undergo multiple freeze-thaw cycles?
Repeated freeze-thaw cycles can cause peptide degradation and aggregation. It is recommended to aliquot reconstituted DSIP into single-use volumes prior to freezing.
How does DSIP compare analytically to Epitalon or Selank?
While all three are synthetic regulatory peptides, DSIP is a nonapeptide (1059.04 Da) focused on delta-wave sleep and HPA-axis modulation, whereas Epitalon is a tetrapeptide (390.35 Da) and Selank is a heptapeptide (751.9 Da). Each compound exhibits distinct HPLC retention times and mass spectra.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.